Toward the elimination of lymphatic filariasis in the Democratic Republic of Congo: progress, perspectives, and strategic directions

The Democratic Republic of Congo (DRC) has achieved important milestones in its national effort to eliminate lymphatic filariasis (LF), a disfiguring neglected tropical disease (NTD) that historically threatened more than 53 million people. Despite persistent challenges related to financing, infrast...

Full description

Bibliographic Details
Published in:	Frontiers in Tropical Diseases
Main Authors:	Sylvain Mupoyi, Jean Kalle Kalenga, Kelly Zongo, Martha Mberu, Naomi Pitchouna Awaca Uvon
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Subjects:	lymphatic filariasis Democratic Republic of Congo elimination mass drug administration neglected tropical diseases WHO targets
Online Access:	https://www.frontiersin.org/articles/10.3389/fitd.2025.1605161/full

Similar Items

Leaving no one behind: hernia, a neglected surgical condition identified during hydrocele surgery camps in Tanzania
by: Kelly Zongo, et al.
Published: (2024-04-01)

Eritrea's blueprint for trachoma elimination: A home-grown model for sustainable impact
by: Gilbert Baayenda, et al.
Published: (2025-03-01)

Morbidity hotspot surveillance: A novel approach to detect lymphatic filariasis transmission in non-endemic areas of the Tillabéry region of Niger
by: Xavier Badia-Rius, et al.
Published: (2023-05-01)

Five years of post-validation surveillance of lymphatic filariasis in Thailand
by: Prapapan Meetham, et al.
Published: (2023-12-01)

Lymphatic filariasis elimination in Kenya: Tracing the journey from 2002-2024 and pathways to achieving 2030 target
by: Michael Ofire Ofire, et al.
Published: (2025-03-01)

Ghana’s path towards eliminating lymphatic filariasis
by: Munawar Harun Koray
Published: (2024-05-01)

Brazil was certified by the World Health Organization for having eliminated lymphatic filariasis: what now?
by: Eduardo Brandão, et al.
Published: (2025-03-01)

A Review of Bed Nets Usage and Sewerage Conditions as Risk Factors for Lymphatic Filariasis in Developing Countries
by: Muhafasya Karunia Azzahra, et al.
Published: (2024-01-01)

Elimination of lymphatic filariasis: Where do we stand so far?
by: Aashna Sinha, et al.
Published: (2023-01-01)

Recurrence of microfilaraemia after triple-drug therapy for lymphatic filariasis in Samoa: Recrudescence or reinfection?
by: Helen J. Mayfield, et al.
Published: (2025-03-01)

Molecular xenomonitoring as an indicator of microfilaraemia prevalence for lymphatic filariasis in Samoa in 2019
by: Maddison Howlett, et al.
Published: (2024-09-01)

Persistent lymphatic filariasis transmission seven years after validation of elimination as a public health problem: a cross-sectional study in TongaResearch in context
by: Harriet L.S. Lawford, et al.
Published: (2025-04-01)

Epidemiology of lymphatic filariasis with special reference to urogenital-manifestations
by: S P Pani, et al.
Published: (2005-01-01)

Bayesian Network Analysis of Lymphatic Filariasis Serology from Myanmar Shows Benefit of Adding Antibody Testing to Post-MDA Surveillance
by: Benjamin F. R. Dickson, et al.
Published: (2022-06-01)

Experience of Health System Personnel in the Implementation of Mass Distribution Campaigns for the Control of Lymphatic Filariasis in Rural Guinea in 2022
by: Akoi Zoumanigui, et al.
Published: (2024-11-01)

Chiluria in a lymphatic filariasis endemic area
by: Paulo Sérgio Ramos de Araújo, et al.
Published: (2018-05-01)

Postelimination Cluster of Lymphatic Filariasis, Futuna, 2024
by: Clément Couteaux, et al.
Published: (2025-03-01)

Dynamical and optimal control analysis of lymphatic filariasis and buruli ulcer co-infection
by: Helen Olaronke Edogbanya Edogbanya, et al.
Published: (2024-09-01)

Lymphatic Filariasis in Brazilian Urban Area (Maceió, Alagoas)
by: Fontes Gilberto, et al.
Published: (1998-01-01)

Evaluating the effectiveness of mass drug administration on lymphatic filariasis transmission and assessment of post-mass drug administration surveillance in Nigeria’s Federal Capital Territory
by: Juliana Ajuma Amanyi-Enegela, et al.
Published: (2025-07-01)

Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope
by: Tsitsi Masiyiwa, et al.
Published: (2024-03-01)

Lymphatic filariasis as an indigenous illness: the local context of a global disease
by: Jonathan Roberts, et al.
Published: (2025-12-01)

Zambia: A Narrative Review of Success and Challenges in Lymphatic Filariasis Elimination
by: Kingford Chimfwembe, et al.
Published: (2024-01-01)

Outcome assessment of the implementation of Mass Drug Administration against lymphatic filariasis in Kalaburagi (Gulbarga) Karnataka, India: A cross-sectional survey
by: Puttamaligaiah Subhas Babu, et al.
Published: (2024-11-01)

Shrinking the lymphatic filariasis map of Zimbabwe: Reassessing the population requiring treatment through confirmatory mapping
by: Nicholas Midzi, et al.
Published: (2025-03-01)

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
by: Morgan E. Lemin, et al.
Published: (2022-10-01)

Epidemiology of Lymphatic Filariasis Antigen and Microfilaria in Samoa, 2019: 7–9 Months Post Triple-Drug Mass Administration
by: Helen J. Mayfield, et al.
Published: (2024-12-01)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
by: Meru Sheel, et al.
Published: (2021-07-01)

An empirical analysis of the effects of schistosomiasis and lymphatic filariasis on macroeconomic output in Ghana
by: Mustapha Immurana, et al.
Published: (2024-05-01)

The effects of variable spatial aggregation on lymphatic filariasis transmission
by: Callum Shaw, et al.
Published: (2025-01-01)

Sensitivity analysis and parameters estimation for the transmission of lymphatic filariasis
by: Mussa A. Stephano, et al.
Published: (2023-09-01)

Sero-antigen prevalence of lymphatic filariasis and risk factors of podoconiosis in Busiriba sub-county, Kamwenge district, Southwestern Uganda, August–September 2018
by: Vicent Mwesigye, et al.
Published: (2024-05-01)

Female genital schistosomiasis: Addressing diagnostic and programmatic gaps to advance elimination efforts
by: Martha Mberu, et al.
Published: (2025-03-01)

An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat
by: Kumar Pradeep, et al.
Published: (2008-01-01)

Time to consider doxycycline in the standard treatment of lymphatic filariasis? Emerging evidence on use of doxycycline as an adjunct to hygiene protocols
by: Mian Zahid Jan Kakakhel, et al.
Published: (2025-03-01)

Lymphatic Filariasis Increases Tissue Compressibility and Extracellular Fluid in Lower Limbs of Asymptomatic Young People in Central Myanmar
by: Janet Douglass, et al.
Published: (2017-09-01)

Knowledge and practices on lymphatic filariasis in patients with filarial morbidity in an endemic area in Northeastern Brazil
by: Márcia Marcondes, et al.
Published: (2024-06-01)

Comparing different lymphatic filariasis patient estimate approaches and results in Ethiopia
by: Belete Mengistu, et al.
Published: (2024-02-01)

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
by: Patricia M. Graves, et al.
Published: (2021-04-01)

Integrated mapping of lymphatic filariasis and podoconiosis: lessons learnt from Ethiopia
by: Heven Sime, et al.
Published: (2014-08-01)